Capvizr
THE DEAL, AT A GLANCE

Sanyou Bio

From the announcement
01Who is involvedBacked by Huatai Zijin, Zero2IPO Industry Investment, BringingFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02What happenedSanyou Bio raised Series C, announced 2026-11-09From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03Why it mattersSanyou Bio's Series C is recorded at $0M in Unclassified, while the company description states that total funding is nearly RMB 300 million.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Sanyou Bio · Financing Record

Explore source-linked visual explanations for Sanyou Bio. Unsupported claims are withheld while source review continues.

Record 15649 · Recorded date: 2026-11-09

What it does

Sanyou Bio: illustrative category image
Illustrative image (biotech lab), not Sanyou Bio's product · Stephane Lesbats (IFREMER, Pôle Images, Centre Bretagne - ZI / CC BY 4.0

Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.

Open record 15649 →

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime